Spin offs

Inbiomotion is a Barcelona-based personalized medicine company incorporated in 2011 with the goal of developing biomarkers that predict bone metastasis to improve the cancer patient’s quality of life.

Iproteos is a biotechnology company focused on the research and development of new therapeutic strategies based on peptidic protease inhibition. Iproteos is developing peptidic protease inhibitors for the treatment of CNS diseases.

Omnia Molecular was devoted to the design and development of anti-infectives targeted at difficult-to-treat infections. Lead compounds were synthesized and optimized using a proprietary technology platform and proved effective in several biological assays.

IRB Barcelona Spin offs

Innovation projects

Innovation projects

<p>Institució Cerca</p>

The Premi Pioner seeks to recognize researchers at CERCA centres who, in the last 18 months, have defended a doctoral thesis that has a clear orientation towards launching or strengthening a technology or product of industrial or commercial interest or that can make a significant contribution to the development of public policies. In 2015, Benjamí Oller, former PhD student in Prof. Ernest Giralt’s lab, was awarded this prize for his thesis, entitled “From bee venom to blood-brain barrier shuttles. Development of minimized apamin derivatives for brain delivery of antibodies and other cargoes”.

More information on this news.

The type of high-risk/high-gain research at the frontiers of knowledge that the ERC promotes often generates unexpected or new opportunities for commercial and societal applications. The ERC is committed to ensure the full exploitation of the excellent, useful ideas it funds. The Proof of Concept funding helps ERC grant-holders bridge the gap between their research and the earliest stage of a marketable innovation.

 

VALUNI 2015 aims to encourage action plans of marketing units to promote technology commercialization via the licensing of patents and/or creation of technology-based companies. Furthermore, it seeks to strengthen technology projects and marketing activities in order to ensure effective technology transfer to the productive sector. The Innovation Department was granted this funding for the project INNOVal 2015.

 

<p>la caixa fundacion</p>

BiomedTec is an IRB Barcelona internal programme supported by the Obra Social la Caixa and devoted to validate early-stage technologies from all disciplines. The development of the BiomedTec programme will foster the transfer of scientific results to the market, thus improving the quality of life of patients with cancer.

The first call was in 2012 and devoted to cancer. Due to the success of this first call, applications were broadened to all therapeutic areas. From the second call onwards it was officially denominated BiomedTec.

The Innovation Department is working to assure the continuation of the programme for the forecoming years.

<p>botin fundacion</p>

The Technology Transfer Programme, run by the Botín Foundation, offers research groups financial and management resources with the aim to ensure the dynamic and effective transfer of knowledge to society and the productive sector. Two IRB Barcelona researchers, namely Drs. Modesto Orozco and Joan Guinovart, were awarded funding through this initiative few years ago. More recently, in 2013 and 2014, respectively, Drs. Eduard Batlle and Raúl Méndez joined this prestigious programme. In 2015, Dr. Salvador Aznar Benitah was also invited to participate in it.

 

News

21 May 2016

Director of IRB Barcelona, Joan Guinovart, was among the hundred innovators and inventors gathered in the second  Kinnernet gathering in Catalonia.

19 May 2016

All biomedical research centres should have a lab devoted to understanding life. How did life come about? How did it evolve? How does it work?

<p>Breast tumours have high levels of LIPG expression (F Slebe, IRB Barcelona)</p>
5 Apr 2016

A study headed by the Institute for Research in Biomedicine (IRB Barcelona) and in collaboration with hospitals around Spain and the Universitat Rovira i Virgili (URV) has unveiled breast

<p>Microscopic structure of mouse testicle tissue (P.Mikolcevic, IRB Barcelona)</p>
30 Mar 2016

Published today in Nature Communications, a study by scientists at the Institute for Research in Biomedicine (IRB Barcelona) headed by ICREA researcher Angel R.

Testimonial

Contact

Cristina Horcajada
Head of Innovation
Tel: +34 93 40 31193